INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
INVO Fertility will present a webcast at the Lytham Partners Fall 2026 Investor Conference, held virtually September 29-30, 2026.
The webcast is scheduled for 11:30 a.m. ET on September 29, and management will host virtual one-on-one investor meetings throughout the event.
INVO Fertility operates four U.S. fertility clinics and sells its INVOcell device to third-party clinics; the announcement contains no new financial or operational data.